During the past decade, Grupo Laser Vision conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grupo Laser Vision" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Grupo Laser Vision" are "Diabetic Macular Edema" (4 trials), "Geographic Atrophy" (3 trials), "Macular Degeneration" (2 trials), "Macular Edema" (2 trials) and "Branch Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Grupo Laser Vision" in a lesser frequency.

Most popular intervention types in "Grupo Laser Vision" are "Drug" (14 trials), "Other" (8 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (10 trials), "Faricimab" (6 trials), "Aflibercept" (4 trials), "Ranibizumab" (4 trials) and "RO7200220" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grupo Laser Vision" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Grupo Laser Vision". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Grupo Laser Vision, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Grupo Laser Vision, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".